The €21 Million Dilution Trap: Capital B's Bitcoin Treasury Strategy and the Warrants Problem Nobody Discusses

Samtoshi
Video

Data indicates a pattern. A European-listed company announces a €21 million capital raise, framed as an aggressive expansion of its Bitcoin treasury. The press release lands, the narrative of institutional adoption gets another paragraph in the bull market story, and the stock ticks up. But for 2025, the baseline is not the headline. The baseline is the table of dilutive instruments buried in the footnotes. The baseline is the warrant schedule.

On August 31, Capital B is scheduled to settle a private placement that will inject €21 million into a company whose primary asset is Bitcoin. The stated goal is to buy 270 BTC, increasing a corporate vault that already holds 3,145 BTC. This sounds like straightforward accumulation. The reality is a balance sheet where every new Bitcoin purchased is funded by a claim on future shares, a trade-off that quantifies at a 24.1% reduction in per-share exposure if all attached warrants are exercised. This is not a simple buy signal. It is a structural conflict between the headline narrative and the arithmetic of shareholder dilution.

Based on my audit experience, specifically my forensic review of capital structures during the 2021 crypto credit expansion, the mechanics here warrant immediate scrutiny. The structure of this raise is not an anomaly; it is the inevitable endpoint of a three-year trend where equity markets are being used as a leveraged wrapper for digital asset exposure. The core question is not whether Capital B will purchase the Bitcoin—it likely will—but who pays the invoice for that purchase, and at what compounding rate.

Context: The Treasury Company Playbook

Bitcoin treasury companies operate on a deceptively simple premise. They are public shell vehicles that use equity or debt issuance to buy and hold Bitcoin. Their 'product' is not software or a blockchain; it is a regulated financial instrument that promises investors downside protection through corporate structure and upside exposure through BTC price appreciation.

MicroStrategy (MSTR) validated this model between 2020 and 2024, transforming from a failing enterprise software firm into the world's largest corporate Bitcoin holder. Its success created a template. Metaplanet in Tokyo copied it. Boyaa Interactive, a gaming firm, copied it with an Asian twist. Capital B is the European iteration of this same strategy, but it has committed a cardinal sin: it has followed the playbook's funding mechanism without matching its sophistication.

The mechanism is the problem. MSTR primarily utilized convertible notes—zero-coupon bonds that convert into equity only if the stock price appreciates to a specified threshold. During the conversion period, the borrowing party's existing shareholders experience zero dilution. This is critical. MSTR optimized for non-dilutive capital during its accumulation phase, buying Bitcoin at scale while temporarily sheltering its shareholders from the cost of that acquisition.

Capital B has instead chosen a private placement of shares bundled with a train of warrants. This is a traditional European pre-IPO financing structure—used by growth-stage mining companies and biotech startups—but it is ill-fitted for a continuous BTC accumulation vehicle. The warrant attachment is not a creative adaptation to European market conditions. It is a signal. Assumption is the adversary of verification; and the assumption that all treasury companies finance identically is incorrect. They do not, and the variance in their financing structures dictates the variance in their risk profile.

Core: A Systematic Teardown of the Capital B Structure

Let me dissect the specific data from this transaction, segment by segment. The offer is for 36,219,070 new shares at €0.58 per unit. Each unit carries four warrants. The strike prices are €0.75, €0.98, and €1.27, carrying a five-year term. In total, the offering includes 144,876,280 warrants, representing a potential share count increase of over 400% compared to the shares being issued today.

The price of the unit's share component is slightly below the current market price of Capital B common stock. This discount exists because the buyer is purchasing a bundled instrument; the share is the asset, and the warrants are the long-term option on further upside. The warrants are a sweetener, designed to secure allocation from a private network of accredited European investors.

Here is where the data leads, and where the narrative starts to break. My analysis of the post-transaction share count, assuming no further issuances and ignoring the unreported older BSA series and convertible debt warrants, shows a base case and a diluted case.

In the immediate post-placement scenario, total shares outstanding will increase from approximately 420.9 million to 457.1 million. The treasury, holding 3,415 BTC after the purchase, yields a per-million-share BTC ratio of 7.4711. Pre-placement, that ratio was 7.4725. This is almost flat, mutable by less than one one-hundredth of a percent. The company may technically claim 'no per-share dilution' in the immediate transaction. Arithmetically, on a spot basis, they are correct.

However, finance is a forward-looking discipline. Treating the spot as the transaction's sole impact is an analytical failure. The warrants outstanding change the total addressable equity. If all 144.9 million warrants and the remaining rights are converted, and if the company does not use the warrant proceeds to purchase additional Bitcoin, the share count balloonn a ratio of approximately 602 million shares. Applying the same 3,415 BTC treasury, the per-million-share BTC amount collapses to 5.67. This represents a decline of 24.1% from the pre-announcement baseline.

A 24% reduction in the primary metric that justifies the stock's existence is not marginal. It is a governance failure. The CEO of a treasury company is not a technologist; their 'software' is the capital structure. The code is the equity schedule. When you review a smart contract and find a 24% slippage on a trade execution, you flag it as a critical vulnerability. When you review a capital raise and find a 24% dilution cliff, the regulatory classification changes, but the engineering discipline does not.

The company's transparency in one area also raises questions about the rest. The stated dilution calculation excludes the still-outstanding warrants from older BSA series placements. It excludes warrants attached to previously issued convertible bonds. It excludes the full 300 million euro TOBAM program, which has undrawn capacity. Inclusion of these instruments could push the eventual dilution past 35%. The information asymmetry between the CEO and the retail shareholder is not a defect—it is a design feature.

At this point in my post-mortem, I look for mitigating mechanisms. Does the company have a buyback program? Not to offset share issuance. Is there a plan to deploy warrant proceeds at the same velocity as share issuance? No. The warrant strike prices—€0.75, €0.98, €1.27—present an embedded yield curve that only becomes value if the stock price triples from its current placement level. If the stock does not reach those strikes, the warrants expire worthless. The company receives no cash, and the 5.67 BTC per million shares' diluted state becomes the actual permanent state. The existing shareholders are left with a smaller slice of a treasury that may not grow.

I have observed this structure in failed mining ventures and dead pre-IPO fintechs. The CEO has effectively given the investor class a free call option on the company's future success. In a rising Bitcoin market, this hides itself because liquidity flows and rising tides lift the absolute share price. In a flat or declining BTC environment, the convexity turns negative. The share price cannot escape this gravitational pull.

Contrarian Angle: What the Bulls Get Right

Criticism can become blindness. Even with these structural distractions, the bulls are not entirely without data points in their defense. The immediate spot dilution is essentially zero. This is not a fiction. The business model's core premise—that owning Bitcoin through a corporate vehicle provides better risk-adjusted returns for certain institutional investors than buying spot BTC or ETF shares—retains merit. European pension funds and insurance companies cannot hold BTC directly. They can hold an EU-registered, MiCA-compliant equity. Capital B offers a compliance wrapper.

The warrants, while dangerous, are not necessarily hostile to existing shareholders. If they are exercised, the company receives €0.75–€1.27 per share in cash. If the share price is trading at €1.27+ during the option period, the proceeds inflow is immediate. If the company's treasury management discipline is maintained—if they execute the standing plan to convert 100% of gross proceeds into Bitcoin at market—then a 100% warrant exercise would result in an additional 144.9 million shares exchanged for approximately 1,100–1,450 BTC (derived from the warrant strike). This would raise the total treasury to roughly 4,500–4,800 BTC. The per-million-share BTC ratio on the fully diluted count rises to 7.8–8.0. Dilution is not the absolute enemy; unfunded dilution is.

Furthermore, the narrative is still powerful. The market is in a bull cycle. MSTR still trades at a premium to its BTC net asset value, implying that investors will pay more for one Bitcoin wrapped in corporate equity than for one Bitcoin held directly. This premium is not irrational. It reflects the belief that management will generate additional value through accretive maneuvers. Capital B is betting it can do the same. The bulls argue that 24% dilution is the price of the expansion, and that the expansion will collapse the share base once Bitcoin's market cap extends.

This analysis is unrelated to operational fundamentals. In my historical audits of failed lending protocols, the warning signs were illiquidity, opaque third-party dependencies, and permissionless strategies. Capital B has none of that. It has custody (reportedly with institutional-grade custodians). It has a transparent on-chain treasury—the 3,415 BTC held across addresses can be verified. It has regulatory jurisdiction, as a public company answerable to European securities law. The asset is not a promise; it is a cryptographic hash secured by the Bitcoin network's proof-of-work. The 'technology' works.

The problem is not the asset. The problem is the packaging of the liability side. The bulls would be correct to focus on the asset; the bears are correct to focus on the share count. The truth is that both are the company.

Takeaway: The Accountability Call

The structure of this raise is not a flaw in the Bitcoin thesis. It is a flaw in the acquisition mechanism. Capital B chose a warrant-dilutive structure because the market rewarded the sector regardless. They chose speed over precision. The decision to include unreported BSA and TOBAM series in the fine print is a violation of the shareholder contract as I define it: full disclosure of all claims on future equity.

Regulation requires that a company disclose material information that might affect a shareholder's investment decision. A 24.1% potential dilution is material. The forward guidance that the dilution is 'neutral' without acknowledging the warrant cliff is misleading. This is where I see the pattern repeating. In 2024-2025, too many companies are treated as 'Bitcoin plays' simply for holding the asset. That is not enough. A company is an equity. The equity's per-share ratio to the asset is the only metric that matters. Capital B's ordinary share count currently sits at about 420 million. If the warrant holders are passive, that share count will be the ceiling. If they are greedy, the count expands by 34%, and anyone who bought at the spot price of €0.58 will own a smaller Bitcoin position than they thought.

The counterpoint is clear: the company can buy more BTC with the warrant cash. It can promise to do so. But my obligation is to state what is known, not what is promised. The ledger remembers everything. The warrant schedule of Capital B is now part of the public ledger of investor expectations. The implied bet is that Bitcoin's rise in the next five years far exceeds the cost of the option dilution. That is a deliberate, unhedged bet. In a bull market, this bet looks genius. In a bear market, the intrinsic value of any share in a treasury company falls to its tangible book value, and its tangible book value is whether the per-share asset ratio survives the next fundraiser.

"It's not the price that punishes you," my mentor in Mumbai used to say. "It's the evaluation of the structure that punishes you." The evaluation here is incomplete, and the structure is the sharpest knife in the drawer. Investors who buy this stock must understand that they are not buying a Bitcoin proxy; they are buying a leveraged option on the CEO's willingness to execute trades at an accretive ratio. Paying the valuation premium for that leverage is fine. Ignoring the warrant cliff is a discipline violation.

This article is not an invitation to short Capital B. It is a request for better disclosure. It is a data point suggesting that every small European treasury company copying MSTR will eventually face the same accounting stress test. The hash power of the Bitcoin network does not decentralize when three pools dominate. The stock of a treasury company does not represent Bitcoin exposure when four types of dilutive securities claim priority over common stock. Show me the on-chain proof that the treasury is whole. Show me the cap table that includes the unaffected instruments. Until then, the baseline is skeptical.